ApprovalTrail

Approval · Notice of Compliance 23971 · 2020

TULISSIN: Notice of Compliance 23971

Issued July 29, 2020

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
23971
Date
July 29, 2020
Product type
Veterinary
Submission
Abbreviated New Drug Submission (ANDS)
Submission class
Other
Canadian reference product
DRAXXIN (Zoetis Canada Inc)

Products in this notice

BrandDINStatus today
TULISSIN02502879Marketed

Medicinal ingredients